Trademark Overview
On Monday, August 4, 2025, a trademark application was filed for DAYBUE STIX with the United States Patent and Trademark Office. The USPTO has given the DAYBUE STIX trademark a serial number of 99319317. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, August 4, 2025. This trademark is owned by Acadia Pharmaceuticals Inc.. The DAYBUE STIX trademark is filed in the Advertising, Business and Retail Services, Pharmaceutical Products, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical preparations for the treatment and prevention of neurologic, genetic, psychologic, and psychiatric diseases and disorders
Promoting awareness of patient support offerings for neurologic, genetic, psychologic, and psychiatric diseases and disorders; Business administrative services for medical referrals
Consultancy in the field of the medical treatment of neurologic, genetic, psychologic, and psychiatric diseases and disorders, including Rett syndrome; Consultancy in the field of the medical diagnosis of neurologic, genetic, psychologic, and psychiatric diseases and disorders, including Rett syndrome; Health care services, namely, providing online information for health care providers, caregivers, and patients in the field of neurologic, genetic, psychologic, and psychiatric diseases and disorders; Health care services, namely, providing information about the benefits of diagnostic tools, medical information regarding disease diagnosis, identification, treatment, and management, and healthcare-related information to patients, caregivers, and healthcare professionals all related to neurologic, genetic, psychologic, and psychiatric diseases and disorders